Staphylococcus epidermidis is recognized as cause of biofilm-associated infections and interest in the development of new approaches for S. epidermidis biofilm treatment has increased. In a previous paper we reported that the supernatant of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 presents an anti-biofilm activity against S. epidermidis and preliminary physico-chemical characterization of the supernatant suggested that this activity is due to a polysaccharide. In this work we further investigated the chemical nature of the anti-biofilm P. haloplanktis TAC125 molecule. The production of the molecule was evaluated in different conditions, and reported data demonstrated that it is produced in all P. haloplanktis TAC125 biofilm growth stages, also in minimal medium and at different temperatures. By using a surface coating assay, the surfactant nature of the anti-biofilm compound was excluded. Moreover, a purification procedure was set up and the analysis of an enriched fraction demonstrated that the anti-biofilm activity is not due to a polysaccharide molecule but that it is due to small hydrophobic molecules that likely work as signal. The enriched fraction was also used to evaluate the effect on S. epidermidis biofilm formation in dynamic condition by BioFlux system.

Anti-biofilm activity of Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm: evidences of a signal molecule involvement? / E., Parrilli; Papa, Rosanna; S., Carillo; Tilotta, Marco; A., Casillo; F., Sannino; Cellini, Andrea; Artini, Marco; Selan, Laura; M. M., Corsaro; M. L., Tutino. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 28:1(2015), pp. 104-113. (Intervento presentato al convegno Meeting of ESCMID Study Group for Biofilms (ESGB): Biofilm-based Healthcare-associated Infections: from Microbiology to Clinics tenutosi a Rome nel 09-10 October 2014) [10.1177/0394632015572751].

Anti-biofilm activity of Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm: evidences of a signal molecule involvement?

PAPA, Rosanna;TILOTTA, MARCO;CELLINI, ANDREA;ARTINI, Marco;SELAN, Laura;
2015

Abstract

Staphylococcus epidermidis is recognized as cause of biofilm-associated infections and interest in the development of new approaches for S. epidermidis biofilm treatment has increased. In a previous paper we reported that the supernatant of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 presents an anti-biofilm activity against S. epidermidis and preliminary physico-chemical characterization of the supernatant suggested that this activity is due to a polysaccharide. In this work we further investigated the chemical nature of the anti-biofilm P. haloplanktis TAC125 molecule. The production of the molecule was evaluated in different conditions, and reported data demonstrated that it is produced in all P. haloplanktis TAC125 biofilm growth stages, also in minimal medium and at different temperatures. By using a surface coating assay, the surfactant nature of the anti-biofilm compound was excluded. Moreover, a purification procedure was set up and the analysis of an enriched fraction demonstrated that the anti-biofilm activity is not due to a polysaccharide molecule but that it is due to small hydrophobic molecules that likely work as signal. The enriched fraction was also used to evaluate the effect on S. epidermidis biofilm formation in dynamic condition by BioFlux system.
2015
antibiofilm; bioflux; dynamic biofilm assay; p.haloplanktis tac125; s.epidermidis biofilm
01 Pubblicazione su rivista::01a Articolo in rivista
Anti-biofilm activity of Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm: evidences of a signal molecule involvement? / E., Parrilli; Papa, Rosanna; S., Carillo; Tilotta, Marco; A., Casillo; F., Sannino; Cellini, Andrea; Artini, Marco; Selan, Laura; M. M., Corsaro; M. L., Tutino. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 28:1(2015), pp. 104-113. (Intervento presentato al convegno Meeting of ESCMID Study Group for Biofilms (ESGB): Biofilm-based Healthcare-associated Infections: from Microbiology to Clinics tenutosi a Rome nel 09-10 October 2014) [10.1177/0394632015572751].
File allegati a questo prodotto
File Dimensione Formato  
Parrilli_Anti-biofilm_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 672.45 kB
Formato Adobe PDF
672.45 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/685158
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 27
social impact